DSpace Home
→
Araştırma Çıktıları / Research Outputs
→
WOS İndeksli Yayınlar Koleksiyonu / WOS Indexed Publications Collection
→
Browsing WOS İndeksli Yayınlar Koleksiyonu / WOS Indexed Publications Collection by Author

Browsing WOS İndeksli Yayınlar Koleksiyonu / WOS Indexed Publications Collection by Author "Ozen, Mirac"

Now showing items 1-3 of 3

Clinical outcomes of cyclin-dependent kinase 4-6 (CDK 4-6) inhibitors in patients with male breast cancer: A multicenter study

Yildirim, Hasan Cagri; Mutlu, Emel; Chalabiyev, Elvin; Ozen, Mirac; Keskinkilic, Merve; On, Sercan; Celebi, Abdussamet; Dursun, Bengu; Acar, Omer; Kahraman, Seda; Aykan, Musa Baris; Kaman, Omur (CHURCHILL LIVINGSTONE, 2022)

Background: Since breast cancer is less common in men than in women, data on the use of new therapeutic agents, including cyclin-dependent kinase 4-6 (CDK 4-6) inhibitors, are limited in patients with metastatic hormone ...
First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer

Esen, Selin Akturk; Ergun, Yakup; Erol, Cihan; Arikan, Rukiye; Er, Muhammed Muhiddin; Atci, Muhammed Mustafa; Topcu, Atakan; Ucar, Gokhan; Akagunduz, Baran; Aykan, Musa Baris; Ozen, Mirac; Baytemur, Naziyet Kose (ASSOC BASIC MEDICAL SCI FEDERATION BOSNIA & HERZEGOVINA SARAJEVO, 2022)

Fluoropyrimidine+cisplatin/oxaliplatin+trastuzumab therapy is recommended for the first-line treatment of human epidermal growth factor receptor 2 (HER2)-positive metastatic gastric adenocarcinoma. However, there is no ...
The prognostic and predictive values of differential expression of exosomal receptor tyrosine kinases and associated with the PI3K/AKT/mTOR signaling in breast cancer patients undergoing neoadjuvant chemotherapy

Guney Eskiler, Gamze; Kazan, Nur; Haciefendi, Ayten; Deveci Ozkan, Asuman; Ozdemir, Kayhan; Ozen, Mirac; Kocer, Havva Belma; Yilmaz, Fahri; Kaleli, Suleyman (2022)

Purpose Cancer cell-derived exosomes are the mediator of the tumor microenvironment and the molecular content of exosomes presents a promising prognostic or predictive marker in tumor progression and the treatment response ...